Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?
- PMID: 20431291
- DOI: 10.1159/000313517
Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?
Abstract
Capecitabine is an oral fluoropyrimidine which is transformed to 5-Fluorouracil inside tumor cells, where it achieves high drug concentrations. Capecitabine is an active drug diffusely utilized in the treatment of various types of tumors, such as breast, colorectal, gastric, head and neck carcinoma. In our experience, capecitabine-induced hypertriglyceridemia does not seem to be a rare adverse effect as it is observed in 10% of treated patients. It is necessary to monitor the lipidic profile of patients treated with capecitabine also in consideration of the frequent presence of comorbidities in cancer populations, the concomitant toxicity related to other drugs used in combination regimens, and cardiovascular effects characteristic of biological target therapy.
Copyright (c) 2010 S. Karger AG, Basel.
Similar articles
-
Capecitabine-induced hypertriglyceridemia: a report of two cases.Anticancer Res. 2006 May-Jun;26(3B):2249-51. Anticancer Res. 2006. PMID: 16821596
-
Capecitabine-induced severe hypertriglyceridemia: report of two cases.Ann Pharmacother. 2006 Feb;40(2):328-31. doi: 10.1345/aph.1G348. Epub 2006 Jan 3. Ann Pharmacother. 2006. PMID: 16391007
-
Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.Anticancer Res. 2007 May-Jun;27(3B):1653-6. Anticancer Res. 2007. PMID: 17595791 Clinical Trial.
-
Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases.Pharmacology. 2012;90(3-4):212-5. doi: 10.1159/000342382. Epub 2012 Sep 13. Pharmacology. 2012. PMID: 23038659 Review.
-
Capecitabine: a review.Clin Ther. 2005 Jan;27(1):23-44. doi: 10.1016/j.clinthera.2005.01.005. Clin Ther. 2005. PMID: 15763604 Review.
Cited by
-
Capecitabine-induced hypertriglyceridemia: a rare but clinically relevant treatment-related adverse event.J Gastrointest Oncol. 2018 Dec;9(6):1213-1219. doi: 10.21037/jgo.2018.07.07. J Gastrointest Oncol. 2018. PMID: 30603144 Free PMC article.
-
Case Report: Various Abnormalities in Lipid and Glucose Metabolism Induced by Capecitabine.Front Oncol. 2021 May 4;11:664475. doi: 10.3389/fonc.2021.664475. eCollection 2021. Front Oncol. 2021. PMID: 34017685 Free PMC article.
-
Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study.Onco Targets Ther. 2014 Jan 8;7:101-10. doi: 10.2147/OTT.S51835. eCollection 2014. Onco Targets Ther. 2014. PMID: 24470761 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical